Evidence map›Paper›PMID 25164622›Full record

ReviewMedicinal research reviews2015

Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Wei Wang, Subhasree Nag, Xu Zhang, Ming-Hai Wang, Hui Wang, Jianwei Zhou, Ruiwen Zhang

Open access · greenAbstract readReview
In one paragraph

Review in Medicinal research reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it, 224 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Wei WangDepartment of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106; Cancer Biology Center, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, 79106.
Subhasree Nag
Xu Zhang
Ming-Hai Wang
Hui Wang
Jianwei Zhou
Ruiwen Zhang
Texas Tech University Health Sciences Center · USTexas Tech University · USChinese Academy of Sciences · CNJiangsu Cancer Hospital · CN

Funding

Novel Small Molecule MDM2 Inhibitors for Pancreatic Cancer TherapyR01CA186662 · NCI · UNIVERSITY OF HOUSTON · PI ZHANG, RUIWEN · 2014 to 2018
$2.4M
Dietary Chemopreventive Components/Oncogene Interaction and CancerR01CA121211 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHANG, RUIWEN · 2007 to 2011
$1.4M
MDM2 AS A NEGATIVE REGULATOR OF P21 WAF1/CIP1R01CA112029 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHANG, RUIWEN · 2005 to 2009
$1.3M
NCI NIH HHS R01 CA112029NCI NIH HHS R01 CA121211NCI NIH HHS R01 CA186662
6 · The paper itself

Abstract

Ribosomes are essential components of the protein synthesis machinery. The process of ribosome biogenesis is well organized and tightly regulated. Recent studies have shown that ribosomal proteins (RPs) have extraribosomal functions that are involved in cell proliferation, differentiation, apoptosis, DNA repair, and other cellular processes. The dysfunction of RPs has been linked to the development and progression of hematological, metabolic, and cardiovascular diseases and cancer. Perturbation of ribosome biogenesis results in ribosomal stress, which triggers activation of the p53 signaling pathway through RPs-MDM2 interactions, resulting in p53-dependent cell cycle arrest and apoptosis. RPs also regulate cellular functions through p53-independent mechanisms. We herein review the recent advances in several forefronts of RP research, including the understanding of their biological features and roles in regulating cellular functions, maintaining cell homeostasis, and their involvement in the pathogenesis of human diseases. We also highlight the translational potential of this research for the identification of molecular biomarkers, and in the discovery and development of novel treatments for human diseases.

Indexed as

DiseaseCell NucleolusHumansMitochondriaRibosomal ProteinsRibosomesStress, PhysiologicalRibosomal Proteinscancerdrug discoveryribosomal proteinribosomopathyRP-MDM2-p53 pathway

Identifiers

PMID25164622
PMCPMC4710177
OpenAlexW2167251825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.